Edge Capital Group LLC Buys 29 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Edge Capital Group LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,906 shares of the healthcare conglomerate’s stock after buying an additional 29 shares during the quarter. Edge Capital Group LLC’s holdings in UnitedHealth Group were worth $1,530,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in UNH. Verdence Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 2.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after buying an additional 342 shares during the last quarter. Bellecapital International Ltd. increased its stake in shares of UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after buying an additional 193 shares during the period. Rise Advisors LLC grew its holdings in UnitedHealth Group by 326.0% during the 4th quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock worth $112,000 after acquiring an additional 163 shares during the last quarter. Gradient Investments LLC lifted its holdings in shares of UnitedHealth Group by 6.3% during the fourth quarter. Gradient Investments LLC now owns 84,278 shares of the healthcare conglomerate’s stock worth $44,370,000 after purchasing an additional 5,023 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its position in UnitedHealth Group by 7.9% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 75,602 shares of the healthcare conglomerate’s stock worth $39,802,000 after purchasing an additional 5,537 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on UNH shares. Barclays raised their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Royal Bank of Canada decreased their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. Robert W. Baird started coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. Finally, Truist Financial reiterated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $578.75.

View Our Latest Report on UNH

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.4 %

Shares of UnitedHealth Group stock opened at $503.28 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market cap of $463.21 billion, a price-to-earnings ratio of 30.76, a PEG ratio of 1.47 and a beta of 0.58. The company’s 50-day moving average price is $490.29 and its 200-day moving average price is $508.39.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the business earned $6.26 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.